Nura Bio closes further financing; names new CEO The Pharma LetterNura Bio secures funding to advance neuroprotective therapies Pharmaceutical TechnologyNeuro Startup Nura Bio Adds $68M to Spare Axons With Its Brain-Penetrating Drug MedCity NewsNura Bio Closes Series A Financing with $68 Million in New Funds, Bringing Total Raised to $140+ Million Business WireNura Bio Raises More Than $140M in Series A Financing FinSMEs
Read More…
Source: https://www.thepharmaletter.com/nura-bio-closes-further-financing-names-new-ceo